The global microencapsulated omega3 powder market is expected to grow at a CAGR of 6.5% during the forecast period, from 2021 to 2030. The market is driven by the increasing awareness about health benefits of omega3 fatty acids and their role in reducing the risk of cardiovascular diseases, obesity, diabetes and other chronic diseases. The growing demand for omega3 supplements in developed countries such as North America and Europe is also driving the growth of this market. However, high cost associated with microencapsulation technology may hamper the growth of this market during the forecast period.
- The global population is increasing and this will lead to an increase in the demand for food. This will lead to an increase in the demand for omega-3s, which can be found in fish oil supplements.
- Omega-3s are important for brain development and function, as well as heart health, so there is a need to find a way to get more of these nutrients into people's diets without eating fish or taking supplements that contain mercury or other contaminants.
- Omega 3 fatty acids have been shown to reduce inflammation throughout the body, which can help with conditions such as arthritis and asthma;.
- Omega 3 fatty acids may also help with depression symptoms by reducing inflammation in the brain. .
- There are many benefits of omega-3s that have been studied extensively and proven by research studies including:.
Industry Growth Insights published a new data on “Microencapsulated Omega3 Powder Market”. The research report is titled “Microencapsulated Omega3 Powder Market research by Types (Alpha-linolenic Acid, Eicosapentaenoic Acid, Docosahexaenoic Acid), By Applications (Supermarket, Convenience Store, Online Store, Others), By Players/Companies KD Pharma, Wincobel, Stepan, Socius Ingredients, Benexia, KKR, Glanbia Nutritionals, SkunyBioscience, BASF, Novotech Nutrition, DSM”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Microencapsulated Omega3 Powder Market Research Report
By Type
Alpha-linolenic Acid, Eicosapentaenoic Acid, Docosahexaenoic Acid
By Application
Supermarket, Convenience Store, Online Store, Others
By Companies
KD Pharma, Wincobel, Stepan, Socius Ingredients, Benexia, KKR, Glanbia Nutritionals, SkunyBioscience, BASF, Novotech Nutrition, DSM
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Microencapsulated Omega3 Powder Market Report Segments:
The global Microencapsulated Omega3 Powder market is segmented on the basis of:
Types
Alpha-linolenic Acid, Eicosapentaenoic Acid, Docosahexaenoic Acid
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Supermarket, Convenience Store, Online Store, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- KD Pharma
- Wincobel
- Stepan
- Socius Ingredients
- Benexia
- KKR
- Glanbia Nutritionals
- SkunyBioscience
- BASF
- Novotech Nutrition
- DSM
Highlights of The Microencapsulated Omega3 Powder Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Alpha-linolenic Acid
- Eicosapentaenoic Acid
- Docosahexaenoic Acid
- By Application:
- Supermarket
- Convenience Store
- Online Store
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microencapsulated Omega3 Powder Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microencapsulated omega-3 fatty acids are a type of dietary supplement that is encapsulated in small, hard pellets. These pellets are easier for the body to absorb and use than traditional omega-3 supplements, which can be bulky and difficult to swallow.
Some of the major players in the microencapsulated omega3 powder market are KD Pharma, Wincobel, Stepan, Socius Ingredients, Benexia, KKR, Glanbia Nutritionals, SkunyBioscience, BASF, Novotech Nutrition, DSM.
The microencapsulated omega3 powder market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Microencapsulated Omega3 Powder Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Microencapsulated Omega3 Powder Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Microencapsulated Omega3 Powder Market - Supply Chain
4.5. Global Microencapsulated Omega3 Powder Market Forecast
4.5.1. Microencapsulated Omega3 Powder Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Microencapsulated Omega3 Powder Market Size (000 Units) and Y-o-Y Growth
4.5.3. Microencapsulated Omega3 Powder Market Absolute $ Opportunity
5. Global Microencapsulated Omega3 Powder Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Microencapsulated Omega3 Powder Market Size and Volume Forecast by Type
5.3.1. Alpha-linolenic Acid
5.3.2. Eicosapentaenoic Acid
5.3.3. Docosahexaenoic Acid
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Microencapsulated Omega3 Powder Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Microencapsulated Omega3 Powder Market Size and Volume Forecast by Application
6.3.1. Supermarket
6.3.2. Convenience Store
6.3.3. Online Store
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Microencapsulated Omega3 Powder Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Microencapsulated Omega3 Powder Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Microencapsulated Omega3 Powder Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Microencapsulated Omega3 Powder Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Microencapsulated Omega3 Powder Demand Share Forecast, 2019-2026
9. North America Microencapsulated Omega3 Powder Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Microencapsulated Omega3 Powder Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Microencapsulated Omega3 Powder Market Size and Volume Forecast by Application
9.4.1. Supermarket
9.4.2. Convenience Store
9.4.3. Online Store
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Microencapsulated Omega3 Powder Market Size and Volume Forecast by Type
9.7.1. Alpha-linolenic Acid
9.7.2. Eicosapentaenoic Acid
9.7.3. Docosahexaenoic Acid
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Microencapsulated Omega3 Powder Demand Share Forecast, 2019-2026
10. Latin America Microencapsulated Omega3 Powder Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Microencapsulated Omega3 Powder Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Microencapsulated Omega3 Powder Market Size and Volume Forecast by Application
10.4.1. Supermarket
10.4.2. Convenience Store
10.4.3. Online Store
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Microencapsulated Omega3 Powder Market Size and Volume Forecast by Type
10.7.1. Alpha-linolenic Acid
10.7.2. Eicosapentaenoic Acid
10.7.3. Docosahexaenoic Acid
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Microencapsulated Omega3 Powder Demand Share Forecast, 2019-2026
11. Europe Microencapsulated Omega3 Powder Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Microencapsulated Omega3 Powder Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Microencapsulated Omega3 Powder Market Size and Volume Forecast by Application
11.4.1. Supermarket
11.4.2. Convenience Store
11.4.3. Online Store
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Microencapsulated Omega3 Powder Market Size and Volume Forecast by Type
11.7.1. Alpha-linolenic Acid
11.7.2. Eicosapentaenoic Acid
11.7.3. Docosahexaenoic Acid
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Microencapsulated Omega3 Powder Demand Share, 2019-2026
12. Asia Pacific Microencapsulated Omega3 Powder Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Microencapsulated Omega3 Powder Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Microencapsulated Omega3 Powder Market Size and Volume Forecast by Application
12.4.1. Supermarket
12.4.2. Convenience Store
12.4.3. Online Store
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Microencapsulated Omega3 Powder Market Size and Volume Forecast by Type
12.7.1. Alpha-linolenic Acid
12.7.2. Eicosapentaenoic Acid
12.7.3. Docosahexaenoic Acid
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Microencapsulated Omega3 Powder Demand Share, 2019-2026
13. Middle East & Africa Microencapsulated Omega3 Powder Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Microencapsulated Omega3 Powder Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Microencapsulated Omega3 Powder Market Size and Volume Forecast by Application
13.4.1. Supermarket
13.4.2. Convenience Store
13.4.3. Online Store
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Microencapsulated Omega3 Powder Market Size and Volume Forecast by Type
13.7.1. Alpha-linolenic Acid
13.7.2. Eicosapentaenoic Acid
13.7.3. Docosahexaenoic Acid
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Microencapsulated Omega3 Powder Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Microencapsulated Omega3 Powder Market: Market Share Analysis
14.2. Microencapsulated Omega3 Powder Distributors and Customers
14.3. Microencapsulated Omega3 Powder Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. KD Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Wincobel
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Stepan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Socius Ingredients
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Benexia
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. KKR
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Glanbia Nutritionals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. SkunyBioscience
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BASF
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Novotech Nutrition
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. DSM
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
